Cannabis Bioscience International Holdings Inc.
Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for … Read more
Cannabis Bioscience International Holdings Inc. (CBIH) - Net Assets
Latest net assets as of August 2025: $-1.25 Million USD
Based on the latest financial reports, Cannabis Bioscience International Holdings Inc. (CBIH) has net assets worth $-1.25 Million USD as of August 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($18.94K) and total liabilities ($1.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.25 Million |
| % of Total Assets | -6579.18% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -15796.52% |
| Growth Volatility | 129010.77 |
Cannabis Bioscience International Holdings Inc. - Net Assets Trend (2007–2025)
This chart illustrates how Cannabis Bioscience International Holdings Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cannabis Bioscience International Holdings Inc. (2007–2025)
The table below shows the annual net assets of Cannabis Bioscience International Holdings Inc. from 2007 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-05-31 | $-1.16 Million | -7.84% |
| 2024-05-31 | $-1.08 Million | -82.37% |
| 2023-05-31 | $-591.66K | -63.87% |
| 2022-05-31 | $-361.05K | -19.88% |
| 2021-05-31 | $-301.17K | -312.37% |
| 2020-05-31 | $-73.03K | -100.11% |
| 2011-05-31 | $65.07 Million | +29.80% |
| 2010-05-31 | $50.13 Million | +126.88% |
| 2009-05-31 | $22.09 Million | +297956.40% |
| 2008-05-31 | $7.41K | +131.92% |
| 2007-05-31 | $-23.22K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cannabis Bioscience International Holdings Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 585927900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (May 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $4.72 Million | % |
| Total Equity | $-1.16 Million | 100.00% |
Cannabis Bioscience International Holdings Inc. Competitors by Market Cap
The table below lists competitors of Cannabis Bioscience International Holdings Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Akshar Spintex Limited
NSE:AKSHAR
|
$3.87 Million |
|
Bebe Stores, Inc.
PINK:BEBE
|
$3.87 Million |
|
ExGen Resources Inc
PINK:BXXRF
|
$3.87 Million |
|
Evion Group NL
AU:EVG
|
$3.87 Million |
|
Manaksia Aluminium Company Limited
NSE:MANAKALUCO
|
$3.87 Million |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
$3.87 Million |
|
Regenx Tech Corp.
OTCQB:RGXTF
|
$3.87 Million |
|
Friday's Dog Holdings Inc.
PINK:FDOGF
|
$3.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannabis Bioscience International Holdings Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -1,079,013 to -1,163,583, a change of -84,570.
- Net loss of 548,820 reduced equity.
- New share issuances of 244,250 increased equity.
- Other factors increased equity by 220,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-548.82K | -47.17% |
| Share Issuances | $244.25K | +20.99% |
| Other Changes | $220.00K | +18.91% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cannabis Bioscience International Holdings Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-05-31 | $-94.86 | $0.00 | x |
| 2008-05-31 | $22.46 | $0.00 | x |
| 2009-05-31 | $14779.54 | $0.00 | x |
| 2010-05-31 | $5931.15 | $0.00 | x |
| 2011-05-31 | $4807.67 | $0.00 | x |
| 2020-05-31 | $-0.01 | $0.00 | x |
| 2021-05-31 | $-0.04 | $0.00 | x |
| 2022-05-31 | $-0.04 | $0.00 | x |
| 2023-05-31 | $-0.06 | $0.00 | x |
| 2024-05-31 | $-0.10 | $0.00 | x |
| 2025-05-31 | $-0.11 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannabis Bioscience International Holdings Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -181.12%
- • Asset Turnover: 9.51x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (5892.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.00% | -117.26% | 0.62x | 0.00x | $-18.68K |
| 2008 | 64782.64% | 12.22% | 969.93x | 5.47x | $4.80 Million |
| 2009 | 50.09% | 15.67% | 1.92x | 1.67x | $8.37 Million |
| 2010 | -27.94% | -18.15% | 1.03x | 1.49x | $-18.24 Million |
| 2011 | 16.82% | 12.53% | 0.92x | 1.46x | $4.24 Million |
| 2020 | 0.00% | -39.03% | 4.55x | 0.00x | $-219.16K |
| 2021 | 0.00% | -20.91% | 5.12x | 0.00x | $-129.19K |
| 2022 | 0.00% | -411.75% | 1.96x | 0.00x | $-849.07K |
| 2023 | 0.00% | -325.91% | 7.30x | 0.00x | $-973.41K |
| 2024 | 0.00% | -261.75% | 4.35x | 0.00x | $-543.44K |
| 2025 | 0.00% | -181.12% | 9.51x | 0.00x | $-432.46K |
Industry Comparison
This section compares Cannabis Bioscience International Holdings Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cannabis Bioscience International Holdings Inc. (CBIH) | $-1.25 Million | 0.00% | N/A | $3.87 Million |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |